Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Evaluation of Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron / Rebetol in Conjunction With a Patient Assistance Program - Non Interventional Observational Study.

Enrolled patients will be recruited to two parallel groups during therapy for Hepatitis C. Patients in the first one will receive a patient assistance program, and patients in the second group will not. All patients will receive PegIntron and Rebetol according to label.

Non-Probability Sample, Commercial product used according to EU label.

Inclusion Criteria:

• According to PegIntron/Rebetol label.
• Only HCV genotype 1 infected patients will be enrolled in the study.

Exclusion Criteria:

• According to PegIntron/Rebetol label.